10 mg & 20 mg tablet: The adverse events seen with Rosuvapac are generally mild and transient. In controlled clinical trials, less than 4% of Rosuvastatin-treated patients were withdrawn due to adverse events.
Immune system disorders: Rare: hypersensitivity reactions including angioedema.
Nervous system disorders: Common: headache, dizziness.
Gastrointestinal disorders: Common: constipation, nausea, abdominal pain. Rare: pancreatitis.
Skin and subcutaneous tissue disorders: Uncommon: pruritus, rash and urticaria.
Musculoskeletal, connective tissue and bone disorders: Common: myalgia. Rare: myopathy (including myositis) and rhabdomyolysis.
General disorders: Common: asthenia.